Endocrine Therapy With or Without Cryoablation for Stage IV Prostate Cancer

NCT02615223 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Stage IV Prostate Cancer

Interventions

PROCEDURE: cryoablation
DRUG: Bicalutamide
DRUG: luteinizing-hormone releasing-hormone (LHRH) agonist

Sponsor

Tianjin Medical University Cancer Institute and Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]